National Institutes of Health criteria consensus statement [83] | European Society for Human Reproduction and Embryology/American Society for Reproductive Medicine consensus statement [20] | Androgen Excess Society position statement [21] |
---|---|---|
Oligo-ovulation and clinical and/or biochemical signs of hyperandrogenism, and exclusion of other aetiologies* | Two out of three of: oligo-ovulation and/or anovulation, clinical and/or biochemical signs of hyperandrogenism, or polycystic ovaries, and exclusion of other aetiologies* | Hyperandrogenism (hirsutism and/or hyperandrogeniaemia), ovarian dysfunction (oligoanovulation and/or polycystic ovaries), and exclusion of other androgen excess related disorders* |